TW202237182A - 纖維化進展抑制劑 - Google Patents
纖維化進展抑制劑 Download PDFInfo
- Publication number
- TW202237182A TW202237182A TW110144377A TW110144377A TW202237182A TW 202237182 A TW202237182 A TW 202237182A TW 110144377 A TW110144377 A TW 110144377A TW 110144377 A TW110144377 A TW 110144377A TW 202237182 A TW202237182 A TW 202237182A
- Authority
- TW
- Taiwan
- Prior art keywords
- fibrosis
- antibody
- amino acid
- acid sequence
- receptor
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| WOPCT/JP2020/044406 | 2020-11-30 | ||
| PCT/JP2020/044406 WO2022113316A1 (ja) | 2020-11-30 | 2020-11-30 | 線維化の進行抑制剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202237182A true TW202237182A (zh) | 2022-10-01 |
Family
ID=81754505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW110144377A TW202237182A (zh) | 2020-11-30 | 2021-11-29 | 纖維化進展抑制劑 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240084020A1 (https=) |
| EP (1) | EP4252771A4 (https=) |
| JP (3) | JPWO2022113316A1 (https=) |
| KR (1) | KR20230114698A (https=) |
| CN (1) | CN116829187A (https=) |
| AU (1) | AU2021385871A1 (https=) |
| CA (1) | CA3199351A1 (https=) |
| CL (1) | CL2023001460A1 (https=) |
| IL (1) | IL303159A (https=) |
| MX (1) | MX2023006164A (https=) |
| TW (1) | TW202237182A (https=) |
| WO (2) | WO2022113316A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5954916B1 (ja) | 2015-04-14 | 2016-07-20 | 中外製薬株式会社 | Ｉｌ−３１アンタゴニストを有効成分として含有する、アトピー性皮膚炎の予防用及び／又は治療用医薬組成物 |
| MX2022005654A (es) | 2019-11-20 | 2022-06-22 | Chugai Pharmaceutical Co Ltd | Preparacion que contiene anticuerpo. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5954916B1 (ja) * | 2015-04-14 | 2016-07-20 | 中外製薬株式会社 | Ｉｌ−３１アンタゴニストを有効成分として含有する、アトピー性皮膚炎の予防用及び／又は治療用医薬組成物 |
-
2020
- 2020-11-30 WO PCT/JP2020/044406 patent/WO2022113316A1/ja not_active Ceased
- 2020-11-30 JP JP2021531123A patent/JPWO2022113316A1/ja not_active Withdrawn
-
2021
- 2021-11-29 IL IL303159A patent/IL303159A/en unknown
- 2021-11-29 AU AU2021385871A patent/AU2021385871A1/en active Pending
- 2021-11-29 EP EP21898137.1A patent/EP4252771A4/en active Pending
- 2021-11-29 MX MX2023006164A patent/MX2023006164A/es unknown
- 2021-11-29 TW TW110144377A patent/TW202237182A/zh unknown
- 2021-11-29 US US18/038,460 patent/US20240084020A1/en active Pending
- 2021-11-29 CN CN202180091901.4A patent/CN116829187A/zh active Pending
- 2021-11-29 CA CA3199351A patent/CA3199351A1/en active Pending
- 2021-11-29 KR KR1020227005324A patent/KR20230114698A/ko active Pending
- 2021-11-29 JP JP2022500682A patent/JPWO2022114165A1/ja not_active Withdrawn
- 2021-11-29 WO PCT/JP2021/043543 patent/WO2022114165A1/ja not_active Ceased
-
2022
- 2022-04-15 JP JP2022067622A patent/JP7802601B2/ja active Active
-
2023
- 2023-05-22 CL CL2023001460A patent/CL2023001460A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230114698A (ko) | 2023-08-01 |
| EP4252771A4 (en) | 2024-10-23 |
| JP2022095913A (ja) | 2022-06-28 |
| CA3199351A1 (en) | 2022-06-02 |
| MX2023006164A (es) | 2023-07-28 |
| WO2022114165A1 (ja) | 2022-06-02 |
| CN116829187A (zh) | 2023-09-29 |
| IL303159A (en) | 2023-07-01 |
| JPWO2022114165A1 (https=) | 2022-06-02 |
| WO2022113316A1 (ja) | 2022-06-02 |
| US20240084020A1 (en) | 2024-03-14 |
| AU2021385871A9 (en) | 2024-05-02 |
| JP7802601B2 (ja) | 2026-01-20 |
| AU2021385871A1 (en) | 2023-06-22 |
| CL2023001460A1 (es) | 2023-12-01 |
| JPWO2022113316A1 (https=) | 2022-06-02 |
| EP4252771A1 (en) | 2023-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101345586B1 (ko) | Ｉｌ-31 길항제를 사용한 신경세포 조직의 통증 및 염증 치료 방법 | |
| JP2011514881A (ja) | 免疫増強剤としてのｔａｍ受容体阻害剤の使用および免疫抑制剤としてのｔａｍ活性化剤の使用 | |
| AU2006236755A1 (en) | Methods for treating and preventing fibrosis by IL-21 / IL-21R antagonists | |
| JP7802601B2 (ja) | 線維化の進行抑制剤 | |
| CN101730545A (zh) | 用于治疗肾病的化合物和方法 | |
| US10160805B2 (en) | Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody | |
| EP2130547A1 (en) | IL-25 for use in the treatment of inflammatory diseases | |
| EA050619B1 (ru) | Ингибитор прогрессирования фиброза | |
| JP2026509231A (ja) | 抗オンコスタチンｍ受容体ベータ抗体を用いて肺線維性疾患又は障害を治療するための方法 | |
| HK40092050A (zh) | 纤维化进展的抑制剂 | |
| Alvarado et al. | Dual targeting of mast cells and TSLP with a bispecific antibody | |
| Potomkina et al. | Lishchuk-Yakymovych K., Chopyak V. | |
| WO2021085295A1 (ja) | 免疫応答抑制剤 | |
| AU2013204177A1 (en) | Methods of Treating Pain and Inflammation in Neuronal Tissue Using IL-31 Antagonists |